523 related articles for article (PubMed ID: 10521763)
1. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
Yaron Y; Cherry M; Kramer RL; O'Brien JE; Hallak M; Johnson MP; Evans MI
Am J Obstet Gynecol; 1999 Oct; 181(4):968-74. PubMed ID: 10521763
[TBL] [Abstract][Full Text] [Related]
2. Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy.
Duric K; Skrablin S; Lesin J; Kalafatic D; Kuvacic I; Suchanek E
Eur J Obstet Gynecol Reprod Biol; 2003 Sep; 110(1):12-5. PubMed ID: 12932863
[TBL] [Abstract][Full Text] [Related]
3. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
4. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.
Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A
Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343
[TBL] [Abstract][Full Text] [Related]
5. Isolated low second-trimester maternal serum beta-human chorionic gonadotropin is not associated with adverse pregnancy outcome.
Endres LK; Krotz S; Grobman WA
Am J Obstet Gynecol; 2003 Sep; 189(3):755-7. PubMed ID: 14526308
[TBL] [Abstract][Full Text] [Related]
6. Association between isolated abnormal levels of maternal serum unconjugated estriol in the second trimester and adverse pregnancy outcomes.
Settiyanan T; Wanapirak C; Sirichotiyakul S; Tongprasert F; Srisupundit K; Luewan S; Traisrisilp K; Tongsong T
J Matern Fetal Neonatal Med; 2016; 29(13):2093-7. PubMed ID: 27480207
[TBL] [Abstract][Full Text] [Related]
7. Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies.
Lepage N; Chitayat D; Kingdom J; Huang T
Am J Obstet Gynecol; 2003 May; 188(5):1354-9. PubMed ID: 12748511
[TBL] [Abstract][Full Text] [Related]
8. Alpha-fetoprotein, free beta-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome.
Wenstrom KD; Owen J; Chu DC; Boots L
Am J Obstet Gynecol; 1997 Nov; 177(5):987-91. PubMed ID: 9396880
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, and unconjugated estriol levels in midtrimester trisomy 18 pregnancies.
Greenberg F; Schmidt D; Darnule AT; Weyland BR; Rose E; Alpert E
Am J Obstet Gynecol; 1992 May; 166(5):1388-92. PubMed ID: 1375811
[TBL] [Abstract][Full Text] [Related]
10. [Serum marker screening during the second trimester for prenatal diagnosis and predicting pregnancy outcome].
Yang L; Zhao L; Jiang J; Liu J; Tao H; Wang J; Wu J
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jul; 35(7):1059-62, 1072. PubMed ID: 26198962
[TBL] [Abstract][Full Text] [Related]
11. First-Trimester and Second-Trimester Maternal Serum Biomarkers as Predictors of Placental Abruption.
Ananth CV; Wapner RJ; Ananth S; D'Alton ME; Vintzileos AM
Obstet Gynecol; 2017 Mar; 129(3):465-472. PubMed ID: 28178056
[TBL] [Abstract][Full Text] [Related]
12. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
Hu Z; Liu X; Li L; Jia C; Li D; Liu R
Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246
[TBL] [Abstract][Full Text] [Related]
13. A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
Burton BK; Prins GS; Verp MS
Am J Obstet Gynecol; 1993 Sep; 169(3):526-30. PubMed ID: 7690522
[TBL] [Abstract][Full Text] [Related]
14. Very low maternal serum chorionic gonadotropin levels in association with fetal triploidy.
Schmidt D; Shaffer LG; McCaskill C; Rose E; Greenberg F
Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):77-80. PubMed ID: 7507646
[TBL] [Abstract][Full Text] [Related]
15. The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome?
Huerta-Enochian G; Katz V; Erfurth S
Am J Obstet Gynecol; 2001 Jun; 184(7):1549-53; discussion 1553-5. PubMed ID: 11408879
[TBL] [Abstract][Full Text] [Related]
16. Elevated second-trimester maternal serum β-human chorionic gonadotropin and amniotic fluid alpha-fetoprotein as indicators of adverse obstetric outcomes in fetal Turner syndrome.
Alvarez-Nava F; Soto M; Lanes R; Pons H; Morales-Machin A; Bracho A
J Obstet Gynaecol Res; 2015 Dec; 41(12):1891-8. PubMed ID: 26369382
[TBL] [Abstract][Full Text] [Related]
17. Second Trimester Serum Biomarker Screen for Fetal Aneuploidies as a Predictor of Preterm Delivery: A Population-Based Study.
Nunthapiwat S; Sekararithi R; Wanapirak C; Sirichotiyakul S; Tongprasert F; Srisupundit K; Luewan S; Tongsong T
Gynecol Obstet Invest; 2019; 84(4):326-333. PubMed ID: 30602167
[TBL] [Abstract][Full Text] [Related]
18. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
19. 2nd-trimester maternal serum marker results are not altered by delayed analysis.
Feldman B; Dvorin E; Phillips T; Kramer RL; Johnson MP; Evans MI
Fetal Diagn Ther; 1998; 13(5):302-4. PubMed ID: 9813424
[TBL] [Abstract][Full Text] [Related]
20. Second-trimester maternal serum screening for fetal Down syndrome: As a screening test for hemoglobin Bart's disease: A prospective population-based study.
Wanapirak C; Piyamomgkol W; Sirichotiyakul S; Tongprasert F; Srisupundit K; Luewan S; Traisrisilp K; Jatavan P; Tongsong T
Prenat Diagn; 2018 Aug; 38(9):700-705. PubMed ID: 29927491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
